The Association of the British Pharmaceutical Industry (ABPI) said today that it would be studying the Office of Fair Trading’s market study into new and proposed medicine distribution arrangements in close detail.
11 Dec 2007 Posted in News Release By Press Office
The choice of distribution arrangements by companies is a matter for their commercial judgement, providing that patient safety, supply chain security, speed of service to pharmacists and general efficiency are maintained.
The ABPI added that the pharmaceutical industry is already working with the UK Government on how medicines can be delivered to the NHS with the maximum efficiency. The OFT recommendations will be considered in parallel with these discussions.